Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""tolerance"" wg kryterium: Temat


Tytuł:
Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID-19 Survivors: A 2-Year Cohort Study.
Autorzy:
Gu X; National Center for Respiratory Medicine, Beijing, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; National Clinical Research Center for Respiratory Diseases, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Huang L; Department of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Li X; Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.
Zhou Y; Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.
Zhang H; National Center for Respiratory Medicine, Beijing, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; National Clinical Research Center for Respiratory Diseases, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Department of Pulmonary and Critical Care Medicine, Capital Medical University, Beijing, China.
Wang Y; National Center for Respiratory Medicine, Beijing, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; National Clinical Research Center for Respiratory Diseases, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Cui D; Department of Pulmonary and Critical Care Medicine, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Yu T; Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.
Wang Y; National Center for Respiratory Medicine, Beijing, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; National Clinical Research Center for Respiratory Diseases, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Cao B; National Center for Respiratory Medicine, Beijing, China.; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.; National Clinical Research Center for Respiratory Diseases, Beijing, China.; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.; Department of Pulmonary and Critical Care Medicine, Capital Medical University, Beijing, China.; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Mar; Vol. 18 (3), pp. e13263.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Olfaction Disorders*
Humans ; Cohort Studies ; Monocytes ; Post-Acute COVID-19 Syndrome ; Quality of Life ; Exercise Tolerance ; Lung ; Survivors
Czasopismo naukowe
Tytuł:
METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma.
Autorzy:
Hu X; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Wu J; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Feng Y; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Ma H; Department of Epidemiology and Biostatistics, International Joint Research Center On Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Zhang E; Department of Epidemiology and Biostatistics, International Joint Research Center On Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Zhang C; Department of Epidemiology and Biostatistics, International Joint Research Center On Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Sun Q; Department of Epidemiology and Biostatistics, International Joint Research Center On Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Wang T; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Ge Y; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Zong D; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Chen W; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
He X; Department of Radiotherapy, The Afliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Sep; Vol. 13 (9), pp. e1361.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
RNA, Long Noncoding*
Nasopharyngeal Neoplasms*
Humans ; Chromatin ; Nasopharyngeal Carcinoma ; Promoter Regions, Genetic ; Radiation Tolerance ; Chromatin Immunoprecipitation ; Methyltransferases ; SOXB1 Transcription Factors
Czasopismo naukowe
Tytuł:
Altered cardiac reserve is a determinant of exercise intolerance in sickle cell anaemia patients.
Autorzy:
Hammoudi N; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Ceccaldi A; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Haymann JP; Département de physiologie et de néphrologie (AP-HP), Centre Hospitalier Universitaire Tenon, Sorbonne Université, INSERM UPMC 1155, Paris, France.
Guedeney P; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Nicolas-Jilwan F; Département de physiologie et de néphrologie (AP-HP), Centre Hospitalier Universitaire Tenon, Sorbonne Université, INSERM UPMC 1155, Paris, France.
Zeitouni M; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Montalescot G; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Lionnet F; Service de médecine interne, Centre de référence de la drépanocytose (AP-HP), Centre Hospitalier Universitaire Tenon, Sorbonne Université, Paris, France.
Isnard R; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Hatem SN; Sorbonne Université, ACTION Study Group, INSERM, UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2022 Jan; Vol. 52 (1), pp. e13664. Date of Electronic Publication: 2021 Aug 21.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Exercise Tolerance*
Anemia, Sickle Cell/*physiopathology
Heart/*physiopathology
Adult ; Anemia, Sickle Cell/complications ; Female ; Humans ; Male ; Prospective Studies ; Ventricular Dysfunction, Left/complications ; Young Adult
Czasopismo naukowe
Tytuł:
New treatments for heart failure and exercise capacity.
Autorzy:
Cohen-Solal A; Université de Paris and Inserm UMR-S 942, Paris, France.
Beauvais F; Cardiology Department, Lariboisière Hospital, AP-HP, Paris, France.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Dec; Vol. 23 (12), pp. 2083-2084. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Exercise Tolerance*
Heart Failure*/therapy
Humans
Opinia redakcyjna
Tytuł:
Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
Autorzy:
Peng M; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Ren J; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Jing Y; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Jiang X; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Xiao Q; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Huang J; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Tao Y; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Lei L; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Wang X; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yang Z; Department of Clinical Laboratory,  The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Chongqing University Cancer Hospital, Chongqing, China.
Yang Z; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhan Q; The Center for Clinical Molecular Medical detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lin C; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Jin G; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhang X; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Zhang L; Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, School of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Journal of extracellular vesicles [J Extracell Vesicles] 2021 Nov; Vol. 10 (13), pp. e12168.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immune Tolerance*
Mutation*
CD8-Positive T-Lymphocytes/*immunology
Creatine/*metabolism
Extracellular Vesicles/*metabolism
Leukemia, Myeloid, Acute/*genetics
Leukemia, Myeloid, Acute/*immunology
Nerve Tissue Proteins/*metabolism
Nucleophosmin/*genetics
Plasma Membrane Neurotransmitter Transport Proteins/*metabolism
Signal Transduction/*immunology
Adult ; Aged ; Biological Transport ; Coculture Techniques/methods ; Female ; Humans ; Leukemia, Myeloid, Acute/blood ; Male ; MicroRNAs/metabolism ; Middle Aged ; Tumor Escape ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł:
ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation.
Autorzy:
Shao Y; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Liu Z; Department of Radiotherapy, The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, China.
Song X; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Sun R; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Zhou Y; Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.; Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, China.; Institute of Cell Therapy, Soochow University, Changzhou, China.
Zhang D; Department of Pathology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Sun H; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Huang J; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Wu C; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Gu W; Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Zheng X; Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.; Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, China.; Institute of Cell Therapy, Soochow University, Changzhou, China.
Jiang J; Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.; Jiangsu Engineering Research Center for Tumor Immunotherapy, Changzhou, China.; Institute of Cell Therapy, Soochow University, Changzhou, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jul; Vol. 13 (7), pp. e1318.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cullin Proteins*/genetics
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/radiotherapy
Humans ; RNA, Circular/genetics ; Adenosine ; Radiation Tolerance/genetics ; Transcription Factors ; AlkB Homolog 5, RNA Demethylase/genetics ; RNA-Binding Proteins
Czasopismo naukowe
Tytuł:
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies.
Autorzy:
Morales JF; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Florida, Orlando, USA.
Muse R; Critical Path Institute, Arizona, Tucson, USA.
Podichetty JT; Critical Path Institute, Arizona, Tucson, USA.
Burton J; Critical Path Institute, Arizona, Tucson, USA.
David S; Critical Path Institute, Arizona, Tucson, USA.
Lang P; Critical Path Institute, Arizona, Tucson, USA.
Schmidt S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Florida, Orlando, USA.
Romero K; Critical Path Institute, Arizona, Tucson, USA.
O'Doherty I; Critical Path Institute, Arizona, Tucson, USA.
Martin F; JDRF, New York, New York, USA.
Campbell-Thompson M; Department of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA.
Haller MJ; Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA.
Atkinson MA; Department of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA.; Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA.
Kim S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Florida, Orlando, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Jul; Vol. 12 (7), pp. 1016-1028. Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/prevention & control
Humans ; Glucose Tolerance Test ; Autoantibodies ; Disease Progression ; Blood Glucose/metabolism
Czasopismo naukowe
Tytuł:
Concomitant systemic inflammation and cellular immunosuppression in patients with Cushing's syndrome.
Autorzy:
van Houten P; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Peng C; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jaeger M; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Herwaarden AE; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
van de Ven AC; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Netea-Maier RT; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jul; Vol. 13 (7), pp. e1314.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Cushing Syndrome*/complications
Humans ; Inflammation/complications ; Immune Tolerance ; Immunosuppression Therapy
Raport
Tytuł:
TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
Autorzy:
Singleton S; Institute of Academic Anaesthesia, Division of Systems Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
Baptista-Hon DT; Institute of Academic Anaesthesia, Division of Systems Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.; Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
Edelsten E; Institute of Academic Anaesthesia, Division of Systems Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
McCaughey KS; Institute of Academic Anaesthesia, Division of Systems Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
Camplisson E; Institute of Academic Anaesthesia, Division of Systems Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
Hales TG; Institute of Academic Anaesthesia, Division of Systems Medicine, School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2021 Apr; Vol. 178 (8), pp. 1855-1868. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Analgesics, Opioid*/pharmacology
Drug Tolerance*
Morphine*/pharmacology
Receptors, Opioid, mu*
Animals ; Cricetinae ; Mice ; Cricetulus ; Mice, Inbred C57BL ; Spiro Compounds ; Thiophenes
Czasopismo naukowe
Tytuł:
Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.
Autorzy:
Lee MT; Department and Graduate Institute of Pharmacology, National Taiwan University, Taipei, Taiwan.; Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
Mackie K; Gill Center for Biomolecular Research, Indiana University, Bloomington, Indiana, USA.; Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA.
Chiou LC; Department and Graduate Institute of Pharmacology, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2023 Apr; Vol. 180 (7), pp. 894-909. Date of Electronic Publication: 2022 Jan 21.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Endocannabinoids*/metabolism
Analgesics, Opioid*/adverse effects
Humans ; Pain Management ; Opioid Epidemic ; Drug Tolerance ; Pain/drug therapy ; Pain/metabolism ; Analgesics/pharmacology ; Receptor, Cannabinoid, CB1
Czasopismo naukowe
Tytuł:
Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial.
Autorzy:
Whinnett ZI; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Shun-Shin MJ; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Tanner M; West Sussex Hospitals NHS Trust, West Sussex, UK.
Foley P; Great Western Hospitals NHS Foundation Trust, Swindon, UK.
Chandrasekaran B; Great Western Hospitals NHS Foundation Trust, Swindon, UK.
Moore P; West Hertfordshire Hospitals NHS Trust, Hertfordshire, UK.; Barts Health NHS Trust, London, UK.
Adhya S; Medway NHS Foundation Trust, Kent, UK.
Qureshi N; Wycombe General Hospital, High Wycombe, UK.
Muthumala A; Barts Health NHS Trust, London, UK.; North Middlesex University Hospital, London, UK.
Lane R; Royal Brompton and Harefield NHS Trust, London, UK.
Rinaldi A; Guy's and St. Thomas's NHS Foundation Trust, London, UK.
Agarwal S; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Leyva F; University Hospitals Birmingham, Birmingham, UK.
Behar J; Royal Brompton and Harefield NHS Trust, London, UK.
Bassi S; Sherwood Forest Hospitals NHS Foundation Trust, UK.
Ng A; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Scott P; Kings College NHS Hospital, London, UK.
Prasad R; Kettering General Hospital, Northampton, UK.
Swinburn J; Royal Berkshire NHS Foundation Trust, Reading, UK.
Tomson J; Royal Free London Foundation NHS Trust, London, UK.
Sethi A; London North West University Healthcare NHS Trust, London, UK.
Shah J; London North West University Healthcare NHS Trust, London, UK.
Lim PB; National Heart and Lung Institute, Imperial College London, London, UK.
Kyriacou A; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Thomas D; Morriston Hospital Regional Cardiac Centre, Wales, UK.
Chuen J; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Kamdar R; Croydon NHS University Hospital, London, UK.
Kanagaratnam P; National Heart and Lung Institute, Imperial College London, London, UK.
Mariveles M; Imperial College Healthcare NHS Trust, London, UK.
Burden L; Imperial College Healthcare NHS Trust, London, UK.
March K; Imperial College Healthcare NHS Trust, London, UK.
Howard JP; National Heart and Lung Institute, Imperial College London, London, UK.
Arnold A; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Vijayaraman P; Geisinger Commonwealth School of Medicine, Geisinger Heart Institute, Scranton, PA, USA.
Stegemann B; National Heart and Lung Institute, Imperial College London, London, UK.
Johnson N; Imperial College Trials Unit, Imperial College London, London, UK.
Falaschetti E; Imperial College Trials Unit, Imperial College London, London, UK.
Francis DP; National Heart and Lung Institute, Imperial College London, London, UK.
Cleland JGF; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Keene D; National Heart and Lung Institute, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 274-283.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Cardiac Resynchronization Therapy*/methods
Male ; Humans ; Female ; Bundle of His ; Cross-Over Studies ; Stroke Volume ; Quality of Life ; Exercise Tolerance ; Ventricular Function, Left ; Oxygen ; Treatment Outcome ; Cardiac Pacing, Artificial/methods ; Electrocardiography/methods
Czasopismo naukowe
Tytuł:
January 2021 at a glance: focus on sex differences, acute heart failure and exercise capacity.
Autorzy:
Tomasoni D; Cardiac Catheterization Laboratory and Cardiology, Cardio-thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Adamo M; Cardiac Catheterization Laboratory and Cardiology, Cardio-thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Metra M; Cardiac Catheterization Laboratory and Cardiology, Cardio-thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Jan; Vol. 23 (1), pp. 1-2.
Typ publikacji:
Journal Article
MeSH Terms:
Exercise Tolerance*
Heart Failure*
Exercise Test ; Female ; Humans ; Male ; Sex Characteristics ; Stroke Volume
Czasopismo naukowe
Tytuł:
Improving physical activity and exercise capacity in heart failure. Taking the first step is always the hardest.
Autorzy:
Ambrosy AP; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Chioncel O; Institute of Emergency for Cardiovascular Diseases 'Professor C.C. Iliescu', University of Medicine and Pharmacy Carol Davila, Bucuresti, Romania.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Sep; Vol. 22 (9), pp. 1734-1736. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Exercise Tolerance*
Heart Failure*
Accelerometry ; Aminobutyrates ; Biphenyl Compounds ; Drug Combinations ; Enalapril ; Exercise ; Humans ; Stroke Volume ; Tetrazoles ; Valsartan
Raport
Tytuł:
IL-34 deficiency impairs FOXP3 Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis.
Autorzy:
Freuchet A; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Salama A; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Bézie S; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Tesson L; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Rémy S; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Humeau R; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Règue H; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Sérazin C; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Flippe L; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Peterson P; Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Vimond N; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Usal C; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Ménoret S; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.; CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes Université, Nantes, France.
Heslan JM; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Duteille F; Chirurgie Plastique Reconstructrice et Esthétique, CHU Nantes, Nantes, France.
Blanchard F; INSERM UMR1238, Bone Sarcoma and remodeling of calcified tissues, Nantes University, Nantes, France.
Giral M; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Colonna M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Anegon I; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Guillonneau C; Nantes Université, CHU Nantes, CNRS, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN5, Nantes, F-44000, France.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 Aug; Vol. 12 (8), pp. e988.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colitis*/immunology
Graft vs Host Disease*/immunology
Interleukins*/deficiency
Interleukins*/genetics
T-Lymphocytes, Regulatory*/immunology
Animals ; Forkhead Transcription Factors ; Homeostasis ; Humans ; Immune Tolerance ; Mice ; Rats
Czasopismo naukowe
Tytuł:
Impact of Right Ventricular Dilatation in Patients with Atrial Septal Defect.
Autorzy:
Nakayama R; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Takaya Y; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Akagi T; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Nakagawa K; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Watanabe N; Division of Medical Support, Okayama University Hospital, Okayama, Japan.
Nobusada S; Division of Medical Support, Okayama University Hospital, Okayama, Japan.
Matsushita T; Division of Medical Support, Okayama University Hospital, Okayama, Japan.
Toh N; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Kanazawa S; Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ito H; Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2020 Apr 27; Vol. 2020, pp. 9509105. Date of Electronic Publication: 2020 Apr 27 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
Exercise Tolerance*
Heart Septal Defects, Atrial*/diagnosis
Heart Septal Defects, Atrial*/physiopathology
Heart Ventricles*/diagnostic imaging
Heart Ventricles*/pathology
Adult ; Correlation of Data ; Exercise Test/methods ; Female ; Humans ; Magnetic Resonance Imaging, Cine/methods ; Male ; Middle Aged ; Organ Size ; Patient Selection
Czasopismo naukowe
Tytuł:
Effects of left ventricular assist device on cardiopulmonary exercise performance.
Autorzy:
Trombara F; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Apostolo A; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Vignati C; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milano, Milan, Italy.
Naliato M; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Ceriani R; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.
Agostoni P; Centro Cardiologico Monzino, University of Milan, IRCCS, Milan, Italy.; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milano, Milan, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Feb; Vol. 22 (2), pp. 381-382. Date of Electronic Publication: 2019 Dec 21.
Typ publikacji:
Letter
MeSH Terms:
Exercise Tolerance*
Heart Failure*/therapy
Heart-Assist Devices*
Exercise Test ; Heart ; Humans ; Ventricular Function, Left
Opinia redakcyjna
Tytuł:
Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease. Letter regarding the article 'Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial'.
Autorzy:
Dandel M; German Centre for Cardiovascular Research (DZHK), partner site, Berlin, Germany.; Cardio Centrum Berlin, Berlin, Germany.
Hetzer R; Cardio Centrum Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1990. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Letter; Comment
MeSH Terms:
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/complications
Heart Failure*/complications
Heart Failure*/drug therapy
Heart Failure*/diagnosis
Ventricular Dysfunction, Left*/complications
Humans ; Sildenafil Citrate/therapeutic use ; Stroke Volume ; Exercise Tolerance ; Double-Blind Method
Raport
Tytuł:
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.
Autorzy:
Guazzi M; Division of Cardiology, University of Milano School of Medicine, San Paolo Hospital, Milan, Italy.
Wilhelm M; Department of Cardiology Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Halle M; Department of Prevention and Sports Medicine, Faculty of Medicine, University Hospital 'Klinikum rechts der Isar', Technical University Munich, Munich, Germany.; DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung), partner site Munich, Munich Heart Alliance, Munich, Germany.
Van Craenenbroeck E; Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.
Kemps H; Department of Cardiology, Máxima Medical Center, Eindhoven, The Netherlands.; Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands.
de Boer RA; University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands.
Coats AJS; Warwick Medical School, University of Warwick, Coventry, UK.
Lund L; Solna, Solna, Karolinska Institutet, Stockholm, Sweden.
Mancini D; Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Borlaug B; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Pieske B; Department of Cardiology, Charité University Medicine, Berlin, Germany.; German Centre for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.; German Heart Center, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Aug; Vol. 24 (8), pp. 1327-1345. Date of Electronic Publication: 2022 Jul 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiology*
Heart Failure*/diagnosis
Heart Failure*/therapy
Dyspnea/diagnosis ; Dyspnea/etiology ; Exercise Test ; Exercise Tolerance/physiology ; Humans ; Stroke Volume/physiology
Czasopismo naukowe
Tytuł:
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.
Autorzy:
Cooper TJ; Stavanger University Hospital, Stavanger, Norway.
Cleland JGF; National Heart Lung Institute, Imperial College, London, UK.; Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.
Guazzi M; Cardiology Department, University of Milano, San Paolo Hospital, Milan, Italy.
Pellicori P; Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
Ben Gal T; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Amir O; Division of Cardiology, Hadassah Medical Center, Faculty of Medicine, Hebrew University Jerusalem Israel & Azrieli Faculty of Medicine, Bar-Ilan University, Zfat, Israel.
Al-Mohammad A; University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, the UK, Sheffield, UK.
Clark AL; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
McConnachie A; Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UK.
Steine K; Department of Cardiology, Akershus University Hospital, Oslo, Norway.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jul; Vol. 24 (7), pp. 1239-1248. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/complications
Heart Failure*/drug therapy
Hypertension, Pulmonary*/etiology
Ventricular Dysfunction, Left*/complications
Aged ; Double-Blind Method ; Exercise Tolerance ; Female ; Humans ; Middle Aged ; Phosphodiesterase 5 Inhibitors/pharmacology ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Quality of Life ; Sildenafil Citrate/therapeutic use ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Tytuł:
Exercise intolerance in heart failure: beyond mitochondrial dysfunction. Letter regarding the article 'Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?'
Autorzy:
Kambic T; Cardiac Rehabilitation Unit, and Department of Research and Education, General Hospital Murska Sobota, Murska Sobota, Slovenia.
Piepoli MF; Heart Failure Unit, G. da Saliceto Hospital, Piacenza, Italy.; Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.
Lainscak M; Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Slovenian Research Agency, Ljubljana, Slovenia.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 May; Vol. 24 (5), pp. 910. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji:
Letter; Comment
MeSH Terms:
Heart Failure*
Exercise/physiology ; Exercise Tolerance/physiology ; Humans ; Mitochondria, Muscle/metabolism ; Muscle, Skeletal ; Muscles ; Oxygen Consumption
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies